Danielle Cooke
Concepts (539)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 27 | 2023 | 53 | 5.770 |
Why?
| | Intracranial Aneurysm | 23 | 2026 | 106 | 5.430 |
Why?
| | Embolization, Therapeutic | 30 | 2026 | 246 | 5.420 |
Why?
| | Endovascular Procedures | 25 | 2026 | 395 | 4.110 |
Why?
| | Central Nervous System Vascular Malformations | 14 | 2026 | 27 | 2.580 |
Why?
| | Cerebral Angiography | 25 | 2024 | 122 | 2.170 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 74 | 2.150 |
Why?
| | Stents | 12 | 2026 | 570 | 2.070 |
Why?
| | Endothelial Cells | 10 | 2026 | 886 | 2.060 |
Why?
| | Biopsy | 8 | 2024 | 1093 | 1.930 |
Why?
| | Stroke | 19 | 2023 | 1287 | 1.820 |
Why?
| | Angiography, Digital Subtraction | 17 | 2025 | 51 | 1.750 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 38 | 1.670 |
Why?
| | Arteriovenous Fistula | 8 | 2025 | 38 | 1.600 |
Why?
| | Robotics | 3 | 2024 | 90 | 1.360 |
Why?
| | Tomography, X-Ray Computed | 19 | 2025 | 2791 | 1.340 |
Why?
| | Brain Ischemia | 10 | 2022 | 362 | 1.080 |
Why?
| | Basilar Artery | 2 | 2018 | 7 | 1.080 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 107 | 1.070 |
Why?
| | Retinoblastoma | 5 | 2023 | 53 | 1.020 |
Why?
| | Fluoroscopy | 8 | 2018 | 180 | 0.990 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 19 | 0.980 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 47 | 0.980 |
Why?
| | Automobile Driver Examination | 1 | 2026 | 9 | 0.950 |
Why?
| | Humans | 159 | 2026 | 147293 | 0.900 |
Why?
| | Feasibility Studies | 6 | 2022 | 1147 | 0.890 |
Why?
| | Magnetic Resonance Imaging | 23 | 2025 | 3980 | 0.870 |
Why?
| | Self-Management | 2 | 2025 | 204 | 0.860 |
Why?
| | Neurosurgery | 2 | 2022 | 41 | 0.850 |
Why?
| | Brain | 18 | 2026 | 3009 | 0.820 |
Why?
| | Iliac Artery | 2 | 2014 | 55 | 0.820 |
Why?
| | Automobile Driving | 1 | 2026 | 159 | 0.800 |
Why?
| | Risk Reduction Behavior | 1 | 2025 | 221 | 0.790 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 159 | 0.790 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 30 | 0.770 |
Why?
| | Vascular Malformations | 5 | 2022 | 53 | 0.760 |
Why?
| | Radiography, Interventional | 5 | 2023 | 128 | 0.760 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 959 | 0.750 |
Why?
| | Middle Aged | 67 | 2026 | 36821 | 0.740 |
Why?
| | Educational Measurement | 1 | 2026 | 332 | 0.740 |
Why?
| | Retrospective Studies | 61 | 2026 | 17560 | 0.740 |
Why?
| | Male | 90 | 2026 | 73950 | 0.730 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 44 | 0.730 |
Why?
| | Thrombectomy | 8 | 2022 | 79 | 0.730 |
Why?
| | Robotic Surgical Procedures | 2 | 2025 | 207 | 0.730 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 125 | 0.730 |
Why?
| | Aneurysm | 3 | 2021 | 37 | 0.730 |
Why?
| | Software | 4 | 2020 | 683 | 0.710 |
Why?
| | Radiosurgery | 8 | 2022 | 400 | 0.710 |
Why?
| | Treatment Outcome | 35 | 2026 | 11947 | 0.650 |
Why?
| | Cerebral Arteries | 4 | 2017 | 59 | 0.650 |
Why?
| | Carotid Stenosis | 1 | 2022 | 107 | 0.640 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 251 | 0.640 |
Why?
| | Female | 89 | 2026 | 80076 | 0.630 |
Why?
| | Balloon Occlusion | 1 | 2020 | 39 | 0.630 |
Why?
| | Neuroimaging | 6 | 2025 | 309 | 0.620 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 75 | 0.610 |
Why?
| | Aged | 51 | 2026 | 26514 | 0.610 |
Why?
| | Veins | 3 | 2022 | 69 | 0.610 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 32 | 0.610 |
Why?
| | Vascular Access Devices | 3 | 2018 | 30 | 0.610 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.600 |
Why?
| | Melphalan | 3 | 2018 | 43 | 0.580 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 120 | 0.560 |
Why?
| | Needles | 2 | 2018 | 63 | 0.560 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 20 | 0.550 |
Why?
| | Transcranial Magnetic Stimulation | 5 | 2020 | 67 | 0.550 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 40 | 0.540 |
Why?
| | Wounds, Stab | 1 | 2018 | 12 | 0.540 |
Why?
| | Jugular Veins | 1 | 2018 | 42 | 0.530 |
Why?
| | Neck Injuries | 1 | 2018 | 22 | 0.530 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 499 | 0.530 |
Why?
| | Nerve Net | 5 | 2020 | 288 | 0.500 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 288 | 0.500 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 20 | 0.500 |
Why?
| | Obsessive-Compulsive Disorder | 3 | 2023 | 61 | 0.490 |
Why?
| | Adult | 52 | 2026 | 41405 | 0.490 |
Why?
| | Angioplasty | 3 | 2022 | 50 | 0.450 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 10 | 0.440 |
Why?
| | Orbital Diseases | 2 | 2018 | 37 | 0.440 |
Why?
| | Disease Management | 3 | 2017 | 654 | 0.440 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.420 |
Why?
| | Renal Dialysis | 1 | 2018 | 467 | 0.410 |
Why?
| | Ventriculostomy | 3 | 2026 | 24 | 0.410 |
Why?
| | Magnetic Fields | 2 | 2014 | 24 | 0.410 |
Why?
| | Neural Pathways | 4 | 2020 | 320 | 0.400 |
Why?
| | Spinal Cord | 4 | 2025 | 383 | 0.400 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 297 | 0.390 |
Why?
| | Cell Separation | 1 | 2013 | 306 | 0.370 |
Why?
| | Pitch Perception | 2 | 2025 | 14 | 0.370 |
Why?
| | Cerebral Infarction | 3 | 2025 | 47 | 0.370 |
Why?
| | Mammary Arteries | 1 | 2012 | 9 | 0.370 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 61 | 0.360 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 41 | 0.360 |
Why?
| | Cerebrovascular Disorders | 2 | 2024 | 106 | 0.360 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 141 | 0.360 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 31 | 0.360 |
Why?
| | Clinical Protocols | 3 | 2018 | 284 | 0.350 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 222 | 0.350 |
Why?
| | Catheters | 4 | 2017 | 74 | 0.350 |
Why?
| | Transcriptome | 4 | 2026 | 1059 | 0.340 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1338 | 0.340 |
Why?
| | Sclerotherapy | 4 | 2022 | 19 | 0.340 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 256 | 0.340 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2026 | 160 | 0.330 |
Why?
| | Radial Artery | 2 | 2021 | 75 | 0.330 |
Why?
| | Temporal Arteries | 1 | 2011 | 45 | 0.330 |
Why?
| | Atherosclerosis | 1 | 2015 | 411 | 0.330 |
Why?
| | Cochlear Implants | 2 | 2025 | 97 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2627 | 0.330 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 45 | 0.320 |
Why?
| | Neuronavigation | 1 | 2010 | 8 | 0.310 |
Why?
| | Surgical Instruments | 1 | 2010 | 51 | 0.310 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 48 | 0.300 |
Why?
| | Aged, 80 and over | 14 | 2026 | 8430 | 0.300 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 34 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 308 | 0.290 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 9 | 0.290 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 572 | 0.290 |
Why?
| | Brain Mapping | 5 | 2020 | 550 | 0.270 |
Why?
| | Adolescent | 25 | 2026 | 22825 | 0.270 |
Why?
| | Connectome | 5 | 2020 | 101 | 0.270 |
Why?
| | Vasodilator Agents | 1 | 2010 | 330 | 0.270 |
Why?
| | Magnetics | 4 | 2016 | 46 | 0.270 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 7 | 0.270 |
Why?
| | Foramen Magnum | 2 | 2021 | 10 | 0.270 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 293 | 0.260 |
Why?
| | Contrast Media | 4 | 2020 | 500 | 0.260 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 22 | 0.260 |
Why?
| | Motivation | 2 | 2022 | 615 | 0.240 |
Why?
| | United Kingdom | 2 | 2025 | 391 | 0.240 |
Why?
| | Young Adult | 18 | 2025 | 14437 | 0.240 |
Why?
| | Licensure | 1 | 2026 | 16 | 0.240 |
Why?
| | Quality Improvement | 2 | 2026 | 1321 | 0.230 |
Why?
| | Child | 26 | 2023 | 22979 | 0.230 |
Why?
| | Speech Perception | 2 | 2025 | 91 | 0.230 |
Why?
| | Prospective Studies | 11 | 2025 | 8164 | 0.230 |
Why?
| | Visitors to Patients | 1 | 2026 | 17 | 0.230 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 76 | 0.230 |
Why?
| | Risk Factors | 10 | 2023 | 11017 | 0.230 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 10 | 0.230 |
Why?
| | Washington | 1 | 2026 | 157 | 0.230 |
Why?
| | Telemedicine | 2 | 2026 | 978 | 0.230 |
Why?
| | Cohort Studies | 11 | 2023 | 6099 | 0.220 |
Why?
| | Iatrogenic Disease | 1 | 2026 | 74 | 0.220 |
Why?
| | Healthy Lifestyle | 1 | 2025 | 38 | 0.220 |
Why?
| | Mutation | 6 | 2021 | 4130 | 0.220 |
Why?
| | Embolectomy | 2 | 2017 | 13 | 0.220 |
Why?
| | Preoperative Care | 3 | 2021 | 381 | 0.220 |
Why?
| | Meningioma | 2 | 2016 | 88 | 0.220 |
Why?
| | Catheterization | 2 | 2017 | 184 | 0.220 |
Why?
| | Drainage | 1 | 2026 | 189 | 0.220 |
Why?
| | Equipment Design | 6 | 2025 | 527 | 0.210 |
Why?
| | Time Factors | 4 | 2025 | 7173 | 0.210 |
Why?
| | Cervical Vertebrae | 2 | 2025 | 170 | 0.210 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.210 |
Why?
| | Perfusion Imaging | 3 | 2022 | 66 | 0.200 |
Why?
| | Infant | 13 | 2023 | 10194 | 0.200 |
Why?
| | Mosaicism | 2 | 2021 | 73 | 0.200 |
Why?
| | Parents | 2 | 2026 | 1428 | 0.200 |
Why?
| | Radiography | 4 | 2014 | 862 | 0.200 |
Why?
| | Microsurgery | 2 | 2021 | 76 | 0.200 |
Why?
| | Transverse Sinuses | 1 | 2023 | 9 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 587 | 0.200 |
Why?
| | Evoked Potentials, Motor | 2 | 2020 | 52 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 3 | 2011 | 104 | 0.190 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 153 | 0.190 |
Why?
| | Swine | 6 | 2018 | 828 | 0.190 |
Why?
| | Blood-Brain Barrier | 2 | 2026 | 166 | 0.190 |
Why?
| | Implosive Therapy | 1 | 2023 | 49 | 0.180 |
Why?
| | Cerebral Cortex | 3 | 2022 | 483 | 0.180 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 207 | 0.180 |
Why?
| | Radiology, Interventional | 1 | 2023 | 49 | 0.180 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2026 | 302 | 0.180 |
Why?
| | Cochlear Implantation | 2 | 2025 | 84 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2017 | 1172 | 0.180 |
Why?
| | Oxygen | 2 | 2025 | 998 | 0.180 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 48 | 0.170 |
Why?
| | Child, Preschool | 15 | 2021 | 12016 | 0.170 |
Why?
| | Materials Testing | 2 | 2020 | 346 | 0.170 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 11 | 0.170 |
Why?
| | Machine Learning | 2 | 2024 | 596 | 0.170 |
Why?
| | Hematoma | 1 | 2021 | 63 | 0.170 |
Why?
| | Actins | 2 | 2013 | 428 | 0.170 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1281 | 0.170 |
Why?
| | Methamphetamine | 1 | 2022 | 75 | 0.170 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 97 | 0.170 |
Why?
| | Gene Expression | 2 | 2017 | 1481 | 0.170 |
Why?
| | Program Evaluation | 1 | 2025 | 952 | 0.170 |
Why?
| | Iodine Compounds | 1 | 2020 | 4 | 0.160 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 31 | 0.160 |
Why?
| | Moyamoya Disease | 1 | 2020 | 20 | 0.160 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 86 | 0.160 |
Why?
| | Brain Infarction | 1 | 2020 | 23 | 0.160 |
Why?
| | Precision Medicine | 1 | 2025 | 464 | 0.160 |
Why?
| | Blood Vessels | 1 | 2022 | 167 | 0.160 |
Why?
| | Growth Disorders | 1 | 2021 | 89 | 0.160 |
Why?
| | Phenotype | 5 | 2021 | 3216 | 0.160 |
Why?
| | Orbit | 2 | 2011 | 67 | 0.160 |
Why?
| | Observer Variation | 2 | 2020 | 358 | 0.160 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 42 | 0.160 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 14 | 0.160 |
Why?
| | Nervous System Diseases | 2 | 2021 | 288 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1550 | 0.160 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 166 | 0.160 |
Why?
| | Recurrence | 3 | 2020 | 1151 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2020 | 87 | 0.150 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 6 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 789 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2025 | 124 | 0.150 |
Why?
| | Unconsciousness | 1 | 2020 | 24 | 0.150 |
Why?
| | Pyrimidinones | 1 | 2020 | 125 | 0.150 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 101 | 0.150 |
Why?
| | Amnesia | 1 | 2019 | 47 | 0.150 |
Why?
| | Polyvinyls | 2 | 2016 | 19 | 0.150 |
Why?
| | Torticollis | 1 | 2019 | 21 | 0.150 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3448 | 0.150 |
Why?
| | Brain Stem | 1 | 2020 | 102 | 0.140 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 41 | 0.140 |
Why?
| | Infant, Newborn | 9 | 2026 | 6543 | 0.140 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 43 | 0.140 |
Why?
| | DCC Receptor | 1 | 2019 | 5 | 0.140 |
Why?
| | Mental Health | 2 | 2024 | 813 | 0.140 |
Why?
| | Mental Health Services | 1 | 2024 | 478 | 0.140 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5476 | 0.140 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 422 | 0.140 |
Why?
| | Models, Neurological | 1 | 2021 | 253 | 0.140 |
Why?
| | Electrocardiography | 3 | 1998 | 675 | 0.140 |
Why?
| | Blood Pressure | 1 | 2025 | 1785 | 0.140 |
Why?
| | Aspirin | 1 | 2022 | 406 | 0.140 |
Why?
| | Rabbits | 2 | 2022 | 654 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 106 | 0.140 |
Why?
| | Pyridones | 1 | 2020 | 210 | 0.140 |
Why?
| | Family Health | 1 | 2019 | 195 | 0.140 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 552 | 0.140 |
Why?
| | Movement Disorders | 1 | 2019 | 69 | 0.140 |
Why?
| | Vascular Patency | 1 | 2018 | 122 | 0.140 |
Why?
| | Cell Count | 1 | 2019 | 321 | 0.140 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 61 | 0.130 |
Why?
| | Migraine Disorders | 1 | 2020 | 115 | 0.130 |
Why?
| | Retinal Vein | 1 | 2018 | 14 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2021 | 252 | 0.130 |
Why?
| | Heterozygote | 1 | 2019 | 317 | 0.130 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1518 | 0.130 |
Why?
| | Endoglin | 1 | 2017 | 19 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 58 | 0.130 |
Why?
| | Biomarkers | 2 | 2026 | 4351 | 0.130 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 99 | 0.130 |
Why?
| | Phlebography | 1 | 2017 | 41 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2017 | 85 | 0.130 |
Why?
| | Prognosis | 9 | 2023 | 4383 | 0.130 |
Why?
| | Predictive Value of Tests | 6 | 2026 | 2133 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2025 | 1174 | 0.120 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 57 | 0.120 |
Why?
| | Memory | 1 | 2019 | 300 | 0.120 |
Why?
| | Diagnostic Errors | 1 | 2018 | 182 | 0.120 |
Why?
| | Retinal Diseases | 1 | 2018 | 101 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 379 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2017 | 208 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 98 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 183 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 428 | 0.120 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.120 |
Why?
| | Depression | 3 | 2022 | 1599 | 0.120 |
Why?
| | Meningeal Arteries | 1 | 2015 | 4 | 0.120 |
Why?
| | Ferrous Compounds | 1 | 2015 | 25 | 0.120 |
Why?
| | Thalamus | 1 | 2017 | 132 | 0.120 |
Why?
| | Renal Artery | 1 | 2016 | 43 | 0.120 |
Why?
| | Magnets | 1 | 2015 | 21 | 0.120 |
Why?
| | Fibroblasts | 4 | 2026 | 1039 | 0.120 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 2 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 616 | 0.110 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 96 | 0.110 |
Why?
| | Filtration | 1 | 2015 | 68 | 0.110 |
Why?
| | American Heart Association | 1 | 2017 | 363 | 0.110 |
Why?
| | Ferric Compounds | 1 | 2015 | 54 | 0.110 |
Why?
| | Aneurysm, False | 1 | 2015 | 46 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2231 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1794 | 0.110 |
Why?
| | Genotype | 1 | 2020 | 1875 | 0.110 |
Why?
| | Blood Glucose | 1 | 2025 | 2359 | 0.110 |
Why?
| | Time-to-Treatment | 1 | 2017 | 258 | 0.110 |
Why?
| | Hearing Loss | 1 | 2019 | 252 | 0.110 |
Why?
| | Hemodynamics | 2 | 2017 | 1127 | 0.110 |
Why?
| | Collateral Circulation | 1 | 2015 | 20 | 0.110 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 29 | 0.110 |
Why?
| | Biopsy, Needle | 1 | 2015 | 186 | 0.110 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 42 | 0.110 |
Why?
| | Lasers | 1 | 2015 | 128 | 0.110 |
Why?
| | Primary Health Care | 1 | 2025 | 1759 | 0.110 |
Why?
| | Drug Carriers | 1 | 2015 | 137 | 0.110 |
Why?
| | Myocardial Infarction | 3 | 1998 | 1213 | 0.110 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 150 | 0.110 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.100 |
Why?
| | DNA, Complementary | 1 | 2014 | 273 | 0.100 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 342 | 0.100 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 10 | 0.100 |
Why?
| | Decision Making | 2 | 2021 | 994 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 337 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 984 | 0.100 |
Why?
| | Reference Values | 1 | 2015 | 800 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2973 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 50 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 63 | 0.100 |
Why?
| | Tungsten | 1 | 2013 | 30 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 724 | 0.100 |
Why?
| | Artifacts | 1 | 2014 | 144 | 0.100 |
Why?
| | Skin | 2 | 2017 | 759 | 0.100 |
Why?
| | Alloys | 1 | 2013 | 37 | 0.090 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 19 | 0.090 |
Why?
| | Neck | 2 | 2023 | 109 | 0.090 |
Why?
| | Ketones | 1 | 2013 | 51 | 0.090 |
Why?
| | Costs and Cost Analysis | 2 | 2026 | 221 | 0.090 |
Why?
| | Carboxypeptidases | 1 | 1992 | 12 | 0.090 |
Why?
| | Paresis | 1 | 2012 | 30 | 0.090 |
Why?
| | Comorbidity | 2 | 2014 | 1672 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2014 | 194 | 0.090 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 52 | 0.090 |
Why?
| | Animals | 9 | 2022 | 38410 | 0.090 |
Why?
| | Zygoma | 1 | 2011 | 7 | 0.090 |
Why?
| | Proteoglycans | 1 | 1992 | 112 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 16 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2022 | 4169 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 130 | 0.080 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 105 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 634 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2019 | 2812 | 0.080 |
Why?
| | Mast Cells | 1 | 1992 | 148 | 0.080 |
Why?
| | Patient Admission | 1 | 2012 | 220 | 0.080 |
Why?
| | Health Personnel | 1 | 2017 | 762 | 0.080 |
Why?
| | Cell Survival | 1 | 2013 | 1111 | 0.080 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 2 | 0.080 |
Why?
| | Angiography | 3 | 2018 | 209 | 0.080 |
Why?
| | Hot Temperature | 1 | 2013 | 396 | 0.080 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 12 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 57 | 0.080 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 37 | 0.070 |
Why?
| | Anxiety Disorders | 2 | 2023 | 376 | 0.070 |
Why?
| | Datasets as Topic | 2 | 2020 | 121 | 0.070 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2024 | 537 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 450 | 0.070 |
Why?
| | Quality of Life | 1 | 2022 | 3246 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2625 | 0.070 |
Why?
| | Hydrocephalus | 1 | 2010 | 114 | 0.070 |
Why?
| | Functional Laterality | 2 | 2020 | 241 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 1996 | 691 | 0.070 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 2017 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 211 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 794 | 0.070 |
Why?
| | RNA | 1 | 2014 | 916 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 91 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 649 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 262 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 252 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 626 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 508 | 0.060 |
Why?
| | Electromyography | 2 | 2020 | 419 | 0.060 |
Why?
| | Cerebellum | 2 | 2019 | 227 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3660 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2025 | 3027 | 0.060 |
Why?
| | Electronic Health Records | 2 | 2024 | 1214 | 0.060 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 26 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2434 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2026 | 113 | 0.060 |
Why?
| | Atlases as Topic | 1 | 2025 | 10 | 0.060 |
Why?
| | Reperfusion | 1 | 2025 | 54 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4604 | 0.050 |
Why?
| | Anxiety | 2 | 2023 | 1149 | 0.050 |
Why?
| | Music | 1 | 2025 | 48 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2018 | 514 | 0.050 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 44 | 0.050 |
Why?
| | Age Distribution | 2 | 2014 | 406 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 6164 | 0.050 |
Why?
| | Camping | 1 | 2023 | 3 | 0.050 |
Why?
| | Fibrosis | 1 | 2026 | 568 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3952 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1280 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2023 | 36 | 0.050 |
Why?
| | Models, Animal | 2 | 2016 | 394 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2026 | 653 | 0.050 |
Why?
| | Physician's Role | 1 | 2024 | 225 | 0.050 |
Why?
| | Glasgow Coma Scale | 1 | 2023 | 218 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 62 | 0.040 |
Why?
| | Technology | 1 | 2022 | 99 | 0.040 |
Why?
| | Psychiatry | 1 | 2024 | 197 | 0.040 |
Why?
| | Pericytes | 1 | 2022 | 42 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 6011 | 0.040 |
Why?
| | Age Factors | 2 | 2021 | 3372 | 0.040 |
Why?
| | Head | 1 | 2022 | 127 | 0.040 |
Why?
| | Sodium | 1 | 2022 | 198 | 0.040 |
Why?
| | Skin Abnormalities | 1 | 2021 | 12 | 0.040 |
Why?
| | Mood Disorders | 1 | 2022 | 145 | 0.040 |
Why?
| | Aging, Premature | 1 | 2021 | 18 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2021 | 69 | 0.040 |
Why?
| | Psychosocial Support Systems | 1 | 2020 | 16 | 0.040 |
Why?
| | Expert Testimony | 1 | 2020 | 43 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 101 | 0.040 |
Why?
| | Intention | 1 | 2022 | 187 | 0.040 |
Why?
| | Hippocampus | 1 | 2026 | 989 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 563 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 5 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 73 | 0.040 |
Why?
| | Headache | 1 | 2021 | 151 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 192 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 2110 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 180 | 0.040 |
Why?
| | Canada | 1 | 2021 | 435 | 0.040 |
Why?
| | Coma | 1 | 2020 | 39 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 22 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 385 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2020 | 180 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 568 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 19 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 84 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 539 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 28 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 60 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 97 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 36 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 379 | 0.040 |
Why?
| | Pyramidal Tracts | 1 | 2019 | 30 | 0.040 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 62 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 44 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 70 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2019 | 78 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 502 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 367 | 0.030 |
Why?
| | Motor Cortex | 1 | 2019 | 65 | 0.030 |
Why?
| | Thiophenes | 1 | 1999 | 117 | 0.030 |
Why?
| | Macrophages | 1 | 2026 | 1529 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1046 | 0.030 |
Why?
| | Social Behavior | 1 | 2020 | 287 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2019 | 137 | 0.030 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 24 | 0.030 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 25 | 0.030 |
Why?
| | Paracentesis | 1 | 2018 | 16 | 0.030 |
Why?
| | Problem Behavior | 1 | 2019 | 101 | 0.030 |
Why?
| | Groin | 1 | 2017 | 13 | 0.030 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.030 |
Why?
| | Coronary Disease | 1 | 2000 | 382 | 0.030 |
Why?
| | Coronary Care Units | 1 | 1998 | 27 | 0.030 |
Why?
| | Punctures | 1 | 2017 | 41 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 198 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 539 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 57 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1302 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 366 | 0.030 |
Why?
| | Echocardiography | 1 | 2000 | 652 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 137 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 381 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2000 | 546 | 0.030 |
Why?
| | Movement | 1 | 2019 | 293 | 0.030 |
Why?
| | Hemorrhage | 1 | 2022 | 832 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2021 | 3022 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 65 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2134 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 272 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 840 | 0.030 |
Why?
| | Smoking | 1 | 2023 | 1483 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 995 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 6 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 6 | 0.030 |
Why?
| | United States | 3 | 2021 | 16313 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 368 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 201 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 330 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1188 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 429 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 107 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 390 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 120 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 596 | 0.030 |
Why?
| | Health Behavior | 1 | 2020 | 799 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 196 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1444 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 285 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 382 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2889 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 10 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 432 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 252 | 0.020 |
Why?
| | Multimodal Imaging | 1 | 2015 | 138 | 0.020 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 3 | 0.020 |
Why?
| | Causality | 1 | 2014 | 129 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1720 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1072 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2018 | 537 | 0.020 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2014 | 335 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 2019 | 639 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 303 | 0.020 |
Why?
| | Chymases | 1 | 1992 | 8 | 0.020 |
Why?
| | California | 1 | 2014 | 477 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 82 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2420 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 131 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2458 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 313 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 85 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2920 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1798 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1912 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7274 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 486 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 116 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5272 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2890 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1675 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 233 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2954 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1504 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 421 | 0.010 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2000 | 13 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 2000 | 210 | 0.010 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 9 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 156 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 82 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 164 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 89 | 0.010 |
Why?
| | Regression Analysis | 1 | 2000 | 1003 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 115 | 0.010 |
Why?
| | Electrodes | 1 | 1998 | 111 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 1998 | 156 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 386 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 332 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 378 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 498 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 253 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 303 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 334 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1998 | 767 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1135 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|